Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
CONCORD DRUGS LTD.
Concord Drugs Ltd.
BSE: 538965
Turnaround Potential
Download real time
56.00
0.00
(
0.00
%)
114.56% Gain from 52W Low
6,346
BSE Volume
BSE
30 Jul, 2025 3:31 PM (IST)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Excel Connect
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Concord Drugs Ltd. - CONCORD, 538965 corporate action history
Check all corporate actions such as stock splits, bonuses, dividends, mergers & acquisitions, rights issues & board meeting announcements for Concord Drugs Ltd.
GET EVENTS ALERTS
LIVE SAMPLE
Daily Digest
Concord Drugs Ltd. Bonus history
Concord Drugs Ltd. has not announced any bonus since Jan 1, 2000.
See all forthcoming Bonus and Splits
Concord Drugs Ltd. Split history
Concord Drugs Ltd. has not split the face value of the share since Jan 1, 2000.
See all forthcoming Bonus and Splits
Concord Drugs Ltd. Dividend history
Concord Drugs Ltd. has not given any dividends since Jan 1, 2000.
See all forthcoming dividends
Board Meetings - Concord Drugs Ltd.
The latest board meeting for Concord Drugs Ltd. took place on 03 Jul 2025, for the purpose of Preferential issue of shares
Ex-Date
Purpose
Notes
03 Jul 2025
Preferential issue of shares
-
27 Jun 2025
Preferential Issue of shares & Others
Inter-alia, to consider 1. the date, time, and venue for convening an ExtraOrdinary General Meeting of the Company. 2. Other business matters.
23 May 2025
Audited Results
-
17 Mar 2025
Preferential Issue of shares & Others
Inter-alia, to consider 1. Increase in Authorized share Capital. 2. Other business matters. (Revised)
11 Jan 2025
Quarterly Results
-
13 Nov 2024
Quarterly Results
-
09 Aug 2024
Quarterly Results
-
30 May 2024
Audited Results
(Revised)
13 Feb 2024
Quarterly Results
-
14 Nov 2023
Quarterly Results
-
See all Board Meetings for Concord Drugs Ltd.
Concord Drugs Ltd. Rights history
Concord Drugs Ltd. has not issued
any
rights since Jan 1, 2000.
See all Rights History for Concord Drugs Ltd.